Literature DB >> 8828610

Longitudinal study on early diagnosis and treatment of phenylketonuria in Poland.

M B Cabalska1, I Nowaczewska, E Sendecka, K Zorska.   

Abstract

Early diagnosis and treatment of phenylketonuria (PKU) in Poland was started in 1965, initially on a voluntary and then on a obligatory basis. Guthrie tests have been used for newborn screening. For confirmation of diagnosis changing with time methods of blood phenylalanine (Phe) and tyrosine estimation were used. In addition, Phe and its urinary metabolites were estimated. A total of 560 cases of classical PKU, 99 mild hyperphenylalaninaemia and six atypical PKU cases were detected. The age of confirmatory estimations was from the 1st to 3rd month, in some cases above 3 months. Pretreatment Phe levels ranged from 12.5 to 70.7 mg/dl. The diet was started on a hospital basis and continued at home, controlled with Guthrie tests with age dependent frequency. Periodical multidimensional controls allowed evaluation of physical and mental development, together with biochemical scores (Hb, RBC, total plasma protein, Phe and tyrosin). In some patients trace elements (copper, iron, zinc and selenium) were also determined. Physical development of treated patients was normal. Biochemical scores presented transient relatively low Hb and iron concentrations especially in the youngest patients. DQ/IQ scores correlated with dietary control and social environment. In adults (age 19-26 years) off diet, mean IQ was 97.2 +/- 15.5 in those with good dietary control and 81.0 +/- 13.8 in those poorly controlled during treatment. In adults the average level of education attained was various types of professional school. Some patients attended or graduated from university.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828610     DOI: 10.1007/pl00014250

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.

Authors:  R GUTHRIE; A SUSI
Journal:  Pediatrics       Date:  1963-09       Impact factor: 7.124

2.  Procedures for testing urine specimens dried on filter paper.

Authors:  H K BERRY
Journal:  Clin Chem       Date:  1959-12       Impact factor: 8.327

3.  Paper chromatographic method for estimation of phenylalanine.

Authors:  H K BERRY
Journal:  Proc Soc Exp Biol Med       Date:  1957-05

4.  [Evaluation of the status of mineral nutrition of children with phenylketonuria treated by a low-phenylalanine diet. II. Zinc].

Authors:  B Cabalska; J Skorkowska-Zieleniewska; M Nowakowska
Journal:  Pediatr Pol       Date:  1987-10

5.  Termination of dietary treatment in phenylketonuria.

Authors:  B Cabalska; N Duczyńska; J Borzymowska; K Zorska; A Koślacz-Folga; K Bozkowa
Journal:  Eur J Pediatr       Date:  1977-11-04       Impact factor: 3.183

6.  Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots.

Authors:  N Arai; K Narisawa; H Hayakawa; K Tada
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

  6 in total
  3 in total

1.  Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies.

Authors:  M Paul; E Petersen; J Szczapa
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia.

Authors:  L G Greeves; C C Patterson; D J Carson; R Thom; M C Wolfenden; J Zschocke; C A Graham; N C Nevin; E R Trimble
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

3.  Predictive equations underestimate resting energy expenditure in female adolescents with phenylketonuria.

Authors:  Meghan E Quirk; Brian J Schmotzer; Rani H Singh
Journal:  J Am Diet Assoc       Date:  2010-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.